BFM
MLSS icon

Boothbay Fund Management’s Milestone Scientific MLSS Stock Holding History

Boothbay Fund Management’s Portfolio MLSS Stock Details MLSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18,293
Closed -$45K – 2079
2021
Q2 		$45K Buy
+18,293
New +$44.4K ﹤0.01% 1767

Other funds holding MLSS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
S
swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boothbay Fund Management's MLSS Position: Q3 2021 in Review

Boothbay Fund Management sold out of Milestone Scientific (MLSS) in Q3 2021, closing a stake of 18,293 shares — an estimated $45K sold.

Boothbay Fund Management first reported a position in MLSS in Q2 2021 and held it in 1 quarter. The position peaked at $45K in Q2 2021. 37 funds tracked by Wall St. Rank hold MLSS as of Q3 2021.

  • Boothbay Fund Management reported no remaining Milestone Scientific position as of Q3 2021 after selling out during the quarter.
  • Boothbay Fund Management sold 18,293 Milestone Scientific shares in Q3 2021, an estimated $45K.
  • Boothbay Fund Management first reported a position in Milestone Scientific in Q2 2021 and held it in 1 quarter.
  • Boothbay Fund Management's Milestone Scientific position peaked at $45K in Q2 2021.
  • 37 funds tracked by Wall St. Rank held Milestone Scientific as of Q3 2021.

Based on Boothbay Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.